Cargando…

Stability Characterization of a Vaccine Antigen Based on the Respiratory Syncytial Virus Fusion Glycoprotein

Infection with Respiratory Syncytial Virus (RSV) causes both upper and lower respiratory tract disease in humans, leading to significant morbidity and mortality in both young children and older adults. Currently, there is no licensed vaccine available, and therapeutic options are limited. During the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Flynn, Jessica A., Durr, Eberhard, Swoyer, Ryan, Cejas, Pedro J., Horton, Melanie S., Galli, Jennifer D., Cosmi, Scott A., Espeseth, Amy S., Bett, Andrew J., Zhang, Lan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072732/ https://www.ncbi.nlm.nih.gov/pubmed/27764150 http://dx.doi.org/10.1371/journal.pone.0164789

Ejemplares similares

Discovery and Characterization of Phage Display-Derived Human Monoclonal Antibodies against RSV F Glycoprotein
por: Chen, Zhifeng, et al.
Publicado: (2016)

Modified mRNA/lipid nanoparticle-based vaccines expressing respiratory syncytial virus F protein variants are immunogenic and protective in rodent models of RSV infection
por: Espeseth, Amy S., et al.
Publicado: (2020)

Adjuvants and the vaccine response to the DS-Cav1-stabilized fusion glycoprotein of respiratory syncytial virus
por: Sastry, Mallika, et al.
Publicado: (2017)

Spectroscopic analysis of chlamydial major outer membrane protein in support of structure elucidation
por: Hepler, Robert W., et al.
Publicado: (2018)

A Cysteine Zipper Stabilizes a Pre-Fusion F Glycoprotein Vaccine for Respiratory Syncytial Virus
por: Stewart-Jones, Guillaume B. E., et al.
Publicado: (2015)

Crystal Structure and Immunogenicity of the DS-Cav1-Stabilized Fusion Glycoprotein From Respiratory Syncytial Virus Subtype B
por: Joyce, M. Gordon, et al.
Publicado: (2019)

A potent broadly neutralizing human RSV antibody targets conserved site IV of the fusion glycoprotein
por: Tang, Aimin, et al.
Publicado: (2019)

Iterative structure-based improvement of a respiratory syncytial virus fusion glycoprotein vaccine
por: Joyce, M. Gordon, et al.
Publicado: (2016)

Structure-Based Design of Head-Only Fusion Glycoprotein Immunogens for Respiratory Syncytial Virus
por: Boyington, Jeffrey C., et al.
Publicado: (2016)

Respiratory syncytial virus elicits enriched CD8(+) T lymphocyte responses in lung compared with blood in African green monkeys
por: Li, Hualin, et al.
Publicado: (2017)

Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein
por: Tian, Daiyin, et al.
Publicado: (2017)

Structure and antigenicity of divergent Henipavirus fusion glycoproteins
por: Isaacs, Ariel, et al.
Publicado: (2023)

Interactions of heparin with key glycoproteins of human respiratory syncytial virus
por: Shi, Deling, et al.
Publicado: (2023)

Transplacental Antibody Transfer of Respiratory Syncytial Virus Specific IgG in Non-Human Primate Mother-Infant Pairs
por: Citron, Michael P., et al.
Publicado: (2021)

The Optimal Concentration of Formaldehyde is Key to Stabilizing the Pre-Fusion Conformation of Respiratory Syncytial Virus Fusion Protein
por: Zhang, Wei, et al.
Publicado: (2019)

Role of oligosaccharides in the structure and function of respiratory syncytial virus glycoproteins
por: Lambert, Dennis M.
Publicado: (1988)

Evaluation of HSV-2 gE Binding to IgG-Fc and Application for Vaccine Development
por: Galli, Jennifer D., et al.
Publicado: (2022)

Helical ordering of envelope‐associated proteins and glycoproteins in respiratory syncytial virus
por: Conley, Michaela J, et al.
Publicado: (2021)

Antigenic and sequence variability of the human respiratory syncytial virus F glycoprotein compared to related viruses in a comprehensive dataset
por: Mas, Vicente, et al.
Publicado: (2018)

Respiratory Syncytial Virus Fusion Glycoprotein Expressed in Insect Cells Form Protein Nanoparticles That Induce Protective Immunity in Cotton Rats
por: Smith, Gale, et al.
Publicado: (2012)

In silico virtual screening of lead compounds for major antigenic sites in respiratory syncytial virus fusion protein
por: Mathew, Shilu, et al.
Publicado: (2021)

1644. A Potent Broadly Neutralizing Antibody Isolated From Human Memory B-cells Binding to Conserved Site IV on the RSV F Protein
por: Vora, Kalpit, et al.
Publicado: (2018)

Protective antigenic sites identified in respiratory syncytial virus fusion protein reveals importance of p27 domain
por: Lee, Jeehyun, et al.
Publicado: (2021)

Emergence of new antigenic epitopes in the glycoproteins of human respiratory syncytial virus collected from a US surveillance study, 2015–17
por: Bin Lu, et al.
Publicado: (2019)

Evaluation of Measles Vaccine Virus as a Vector to Deliver Respiratory Syncytial Virus Fusion Protein or Epstein-Barr Virus Glycoprotein gp350
por: Mok, Hoyin, et al.
Publicado: (2012)

Molecular Evolution of Attachment Glycoprotein (G) and Fusion Protein (F) Genes of Respiratory Syncytial Virus ON1 and BA9 Strains in Xiamen, China
por: Sun, Yong-Peng, et al.
Publicado: (2022)

Original Antigenic Sin and Respiratory Syncytial Virus Vaccines
por: Tripp, Ralph A., et al.
Publicado: (2019)

Herpesvirus Glycoproteins Undergo Multiple Antigenic Changes before Membrane Fusion
por: Glauser, Daniel L., et al.
Publicado: (2012)

Requirements for Human Respiratory Syncytial Virus Glycoproteins in Assembly and Egress from Infected Cells
por: Batonick, Melissa, et al.
Publicado: (2011)

Features of the Human Antibody Response against the Respiratory Syncytial Virus Surface Glycoprotein G
por: Borochova, Kristina, et al.
Publicado: (2020)

Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor
por: Roymans, Dirk, et al.
Publicado: (2017)

2729. mRNA Vaccines Encoding Conserved Influenza Antigens Induce Robust and Durable Immunity in Rhesus Macaques
por: Flynn, Jessica, et al.
Publicado: (2019)

Structure and immunogenicity of pre-fusion-stabilized human metapneumovirus F glycoprotein
por: Battles, Michael B., et al.
Publicado: (2017)

A novel pre-fusion conformation-specific neutralizing epitope on the respiratory syncytial virus fusion protein
por: Mousa, Jarrod J., et al.
Publicado: (2017)

Dual Role of Respiratory Syncytial Virus Glycoprotein Fragment as a Mucosal Immunogen and Chemotactic Adjuvant
por: Kim, Sol, et al.
Publicado: (2012)

Ephedrae Herba and Cinnamomi Cortex interactions with G glycoprotein inhibit respiratory syncytial virus infectivity
por: Fujikane, Aya, et al.
Publicado: (2022)

The protective immunity induced by intranasally inoculated serotype 63 chimpanzee adenovirus vector expressing human respiratory syncytial virus prefusion fusion glycoprotein in BALB/c mice
por: Huang, Lei, et al.
Publicado: (2022)

Development of surface engineered antigenic exosomes as vaccines for respiratory syncytial virus
por: Hong, Suyeon, et al.
Publicado: (2021)

Sucrose stabilization of Respiratory Syncytial Virus (RSV) during nebulization and experimental infection
por: Grosz, Drew D, et al.
Publicado: (2014)

The Incidence and Clinical Burden of Respiratory Syncytial Virus Disease Identified through Hospital Outpatient Presentations in Kenyan Children
por: Okiro, Emelda A., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_bp2t1l1lj5hi7v6t0cvkft310e